All In MedTech

Device Trial Radar · NCT04625348

A Multicentre Clinical Test of the Ultracore Repose® Mattress to Prevent Pressure Ulcers Cat. II-IV in Nursing Homes

A Multicentre Clinical Test of the Ultracore Repose® Mattress (Frontier Therapeutics Ltd) to Prevent Pressure Ulcers Cat. II-IV in Belgian Nursing Homes

Last checked: Nov 20, 2026Latest source record: Nov 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Feb 15, 2020

Primary completion

Nov 5, 2020

Study completion Nov 5, 2020

Sponsor

Lead sponsor
University GhentAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 12, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
All sexes, from 66 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A mixed method desgin study will be conducted to study pressure ulcer incidence Cat. II-IV (including deep- tissue injury,unstageable), not associated with the use of medical devices, on the Ultracore Repose® mattress (Frontier therapeutics Ltd) and to study differences in caretakers' experiences and perceptions when using the Ultracore Repose® mattress versus the Repose overlay mattress®

Conditions

  • Pressure Ulcer

Interventions

  • Ultracore Repose® mattressDevice

    residents will be placed on the Ultracore Repose® mattress for the daily care during 14 days

  • experiences and perceptions of healthcare workersOther

    Three focus groups will be set- up at the end of the study to provide insights into how caregivers think about the product and to provide a deeper understanding of the difference between the use of the Ultracore Repose® mattress (versus the Repose overlay mattress® and an alternating air mattress)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence rate of pressure ulcers Cat. II-IVTime frame: 14 days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Bocasa

    Heusden-Zolder, Limburg, Belgium

  • Residentie Kartuizerhof - Vulpia

    Lierde, Oost-Vlaanderen, Belgium

  • Woonzorgcentrum Heilig Hart

    Oudenaarde, Oost-Vlaanderen, Belgium

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.